Anemia of chronic kidney disease

Disease-a-Month

Volumn 61, Issue 10, 2015, Pages 421-424

  Kutuby, Fouad ^a   Wang, Sarah ^a   Desai, Chaitanya ^a   Lerma, Edgar V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANEMIC AGENT; ERYTHROPOIETIN; ERYTHROPOIETIN STIMULATING AGENT; UNCLASSIFIED DRUG;

ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DEPRESSION; DYSPNEA; ERYTHROCYTE TRANSFUSION; FATIGUE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; PATHOGENESIS; REVIEW; CHRONIC KIDNEY FAILURE; COMPLICATION;

ANEMIA; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84946474880     PISSN: 00115029     EISSN: 15578194     Source Type: Journal    
DOI: 10.1016/j.disamonth.2015.08.002     Document Type: Review

References (15)

1. Kazmi W.H., Kausz A.T., Khan S., et al. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 2001, 38(4):803-812.
2. Astor B.C., Muntner P., Levin A., et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002, 162(12):1401-1408.
3. Reindl-Schwaighofer R., Oberbauer R. Blood disorders after kidney transplantation. Transplant Rev (Orlando) 2014, 28(2):63-75.
4. Tomosugi N., Kawabata H., Wakatabe R., et al. Detection of serum hepcidin in renal failure and inflammation by using Protein Chip System. Blood 2006, 108(4):1381-1387.
5. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306(5704):2090-2093.
6. Tsuchihashi D., Abe T., Komaba H., et al. Serum pro-hepcidin as an indicator of iron status in dialysis patients. Ther Apher Dial 2008, 12(3):226-231.
7. Ly J., Marticorena R., Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004, 44(4):715-719.
8. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47:S1-S146, 2006 (suppl 3).
9. Levin A., Thompson C.R., Ethier J., Carlisle E.J., et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999, 34(1):125-134.
10. Collins A.J., Ma J.Z., Ebben J. Impact of hematocrit on morbidity and mortality. Semin Nephrol 2000, 20(4):345-349.
11. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney inter., Suppl. 2012;2:279-335.
12. Kidney Foundation: IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001 Jan;37(1 Suppl 1):S182-238.
13. Valliant Amanda, et al. Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide. Int J Nanomedicine 2013, 8:3297-3307.
14. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006, 355(20):2085-2098.
15. Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulatingagent hyporesponsiveness. Nephrology (Carlton). 2007,12(4):321-330.